Filing Details

Accession Number:
0001012975-18-001040
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-22 16:22:11
Reporting Period:
2018-08-01
Accepted Time:
2018-08-22 16:22:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069308 Acer Therapeutics Inc. ACER Pharmaceutical Preparations (2834) 320426967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1133921 Helmut Schuhsler C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1398596 Stefan Fischer C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1398598 Hubert Birner C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
Yes No Yes No
1639971 Luc Marengere C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
Yes No Yes No
1640880 L.p. Vii Ventures Science Life Tvm C/O Tvm Capital Group
204, Rue Notre-Dame Ouest, Bureau 350
Montreal A8 H2Y 1T3
Yes No Yes No
1718117 Gary Leatt C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1750983 Reshentha Beeby C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-01 275,000 $18.00 1,697,709 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. These shares are directly held by TVM Life Science Ventures VII L.P. ("TVM VII LP"). TVM Life Science Ventures VII (GP) Ltd. ("TVM VII GP Ltd") is the general partner of TVM VII LP. Hubert Birner ("Birner"), Stefan Fischer ("Fischer"), Helmut Schuhsler ("Schuhsler"), Luc Marengere ("Marengere"), Reshentha Beeby ("Beeby"), and Gary Leatt ("Leatt") are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Beeby and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer.